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Mouse trophoblast stem (TS) cells can be grown indefinitely in vitro with FGF4 and embryonic fibroblast conditioned media (EFCM).
Here, we report that the active protein components of EFCM include TGF-h and the related factor activin, and that long-term continuous TS
cell proliferation is possible in media supplemented with only serum, FGF4, and TGF-h. As trophoblasts are an epithelial cell type, the
promotion of TS cell proliferation represents an unusual function for TGF-h and activin since TGF-h in particular is well known as an
inhibitor of nontransformed epithelial cell proliferation. Our data suggest that constitutive FGF signaling in TS cells selectively inhibits the
ability of TGF-h to repress c-myc expression, a central component of the TGF-h cytostatic transcriptional response previously observed to be
lost in other epithelial cell types upon oncogenic Ras transformation.
D 2004 Elsevier Inc. All rights reserved.
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Delineating the precise extracellular environments
required for mammalian stem cell renewal will both further
the experimental study of stem cell behavior as well as
advance the application of stem cell technologies in the
clinical arena. Recently, in vitro culture conditions have
been identified for the continuous growth of mouse
trophoblast stem (TS) cells (Tanaka et al., 1998). TS cells
can be isolated from blastocysts or extraembryonic ecto-
derm and retain the capacity to differentiate into all
trophoblast subtypes of the placenta when injected into
blastocysts. Besides their usefulness as a model stem cell
system, TS cells studied in vitro will likely provide insight
into the pathogenesis of defects in placental development
and physiology. Full use of the TS cell system, however, has0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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of factors required for TS cell growth. Currently, TS cells
are known to require fibroblast growth factor 4 (FGF4), as
well as embryonic fibroblast feeder layers or the embryonic
fibroblast conditioned media (EFCM) collected from these
feeders (Tanaka et al., 1998). Removal of these factors leads
to postmitotic differentiation largely into a trophoblast
subtype called trophoblast giant cells.
Here, we identify TGF-h and activin as key protein
components of EFCM involved in the maintenance of TS
cell proliferation. TGF-h and activin are members of the
TGF-h superfamily of secreted polypeptides, which have
critical roles in regulating many developmental and physio-
logical processes (Chang et al., 2002). TGF-h itself initiates
cellular responses upon binding its heterotetrameric trans-
membrane receptor complex composed of type I (ThRI) and
type II (ThRII) receptors, both serine–threonine kinases,
whereas activin binds the ActRIB receptor in conjunction
with either ActRIIA or ActRIIB (Derynck and Zhang, 2003).
TGF-h and activin receptors both transduce signals largely
through the phosphorylation and induced nuclear trans-275 (2004) 158–169
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Smad4 regulate gene expression by interacting with a large
group of transcriptional coactivators and corepressors
(Derynck and Zhang, 2003; Massague and Wotton, 2000).
TGF-h and activin receptor signaling can evoke virtually
identical transcriptional responses within the same cell type,
in accord with the complete amino acid identity between the
L45 loop of their type I receptor cytoplasmic domain and the
function of this loop as a major determinant of Smad-
dependent signaling specificity (Carcamo et al., 1994; Chen
et al., 1998; Feng and Derynck, 1997).
G1 cell cycle arrest is an important epithelial cell type
response towards TGF-h, and altered TGF-h responsiveness
is thought to be a major factor contributing to epithelial cell
tumorigenesis (Ten Dijke et al., 2002). The TGF-h
cytostatic response is largely Smad dependent and is
mediated by altered transcription of a relatively small set
of cell cycle regulatory genes (Kang et al., 2003). In
particular, TGF-h induces mRNA expression of p15Ink4b
and p21Cip1, which encode two cyclin-dependent kinase
(Cdk) inhibitors, and down-regulates the expression of Id1,
Id2, and Id3, which encode proteins that both promote cell
cycle progression as well as inhibit cell differentiation
programs induced by basic helix-loop-helix transcription
(bHLH) factors (Kang et al., 2003; Norton, 2000; Ten Dijke
et al., 2002). Perhaps most importantly, TGF-h down-
regulates mRNA expression of c-myc, which encodes a
ubiquitous short-lived transcription factor central to cell
cycle progression (Alexandrow and Moses, 1995). c-Myc
down-regulation not only deprives cells of a growth
stimulus in its own right, but also directly or indirectly
promotes p15Ink4b and p21Cip1 mRNA induction upon
TGF-h stimulation (Claassen and Hann, 2000; Feng et al.,
2002; Seoane et al., 2001; Staller et al., 2001; Warner et al.,
1999). These characteristics explain the ability of ectopic c-
Myc expression to prevent TGF-h-induced cell cycle arrest
(Alexandrow and Moses, 1995; Claassen and Hann, 2000).
Furthermore, a selective inability to repress c-myc mRNA
expression may explain why some cells transformed with
oncogenic Ras are resistant to TGF-h-induced growth
inhibition (Chen et al., 2001), although the basis for the
phenomenon in general remains unclear (Derynck and
Zhang, 2003). In TS cells, which are epithelial in origin,
we find that a similar selective inhibition of the TGF-h
cytostatic transcriptional program occurs in response to
constitutive FGF signaling.Materials and methods
Cells, cell culture reagents, and media
The TS cell lines EGFP-TS3.5, TSInk4a, and TSCMI
have been described previously (Erlebacher et al., 2002;
Tanaka et al., 1998). Cells were grown on non-gelatized
tissue culture plastic in 378 humidified incubators contain-ing 5% CO2 and were routinely passaged every 2–3 days.
TS media were based upon DMEM/F-12 with 15 mM
Hepes (Invitrogen, Carlsbad, CA, catalog #11330-032) and
contained 20% FCS (HyClone, Logan, UT), 2 mM
glutamine, 100 U/ml penicillin, 100 Ag/ml streptomycin,
1 mM sodium pyruvate, and 100 AM beta-mercaptoethanol
and was supplemented with 25 ng/ml human FGF4 (R&D
Systems, Minneapolis, MN) plus 1 Ag/ml heparin (Sigma,
St. Louis, MO). Recombinant human TGF-h1, recombinant
human Activin A, human ActRII/Fc (Sf21-expressed), and
recombinant mouse follistatin were purchased from R&D
Systems and used at concentrations of 2 ng/ml, 10 ng/ml,
5 Ag/ml, and 1 Ag/ml, respectively. Neutralizing anti-TGF-h
antibodies (clone 1D11) were the generous gift of Genzyme
(Cambridge, MA), and control mouse IgG antibodies were
purchased from ICN (Aurora, OH); these antibodies were
used with a concentration of 1 Ag/ml. EFCM was an 80%
volume/volume concentration of a low bicarbonate DMEM
basal media conditioned for 3 days with embryonic
fibroblasts (Specialty Media, Phillipsburg, NJ), with FCS
adjusted to a final 20% concentration as described pre-
viously (Erlebacher et al., 2002).
Growth curves
EGFP-TS3.5 or TSInk4a cells (passage n = 25–45) were
seeded in triplicate at a density of 80,000 or 20,000 cells,
respectively, per 12-well tissue culture dish in 1 ml TS
media containing FGF4/heparin. Every 3 days, all cells were
trypsinized, washed twice in TS media, and passaged
equivalently (1:4–1:8 for TSFGP, 1:8–1:20 for TSInk4a).
The remaining cells were resuspended in PBS/1% FCS/5
mM EDTA and counted on a BD Biosciences FACSCalibur
using CellQuest software for analysis (San Diego, CA).
Total cell numbers were back calculated from 1 min of
acquisition at the high flow rate (1 Al/s).
RNA analysis
To determine TSCMI mRNA expression levels in
response to TGF-h alone, cells growing in TS media
containing FGF4/heparin were plated 2 days before the
direct addition of TGF-h1. For experiments determining
TGF-h transcriptional responses in TSCMI as influenced
by the presence or absence of FGF4, cells were plated 2
days before the 0-h time point and the plates were rinsed
twice with PBS before the addition of fresh prewarmed TS
media with or without FGF4/heparin and with either TGF-
h or anti-TGF-h antibodies. For similar experiments with
EGFP-TS3.5 (n = 30–40), we took two approaches using
cells growing N1.5 months in TS media containing FGF4/
heparin and TGF-h. In the first approach, we plated the
cells 3 days before the zero time point and at 24 h rinsed
the plate twice with PBS and replaced the media with fresh
TS media containing only FGF4/heparin. At 0 h, the plates
were treated as above. In the second approach, we
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containing FGF4/heparin plus TGF-h, TGF-h alone, FGF4/
heparin plus anti-TGF-h antibodies, or anti-TGF-h anti-
bodies alone. RNA was prepared at 24 h. Lastly, for the
effects of selective FGF4 or TGF-h withdrawal, EGFP-
TS3.5 cells growing N1.5 months in TS media containing
FGF4/heparin and TGF-h were trypsinized and an aliquot
of these cells was immediately used to prepare the day 0
mRNA. The remaining cells were replated for days 1, 2,
and 3 time points in appropriately supplemented TS media.
Care was taken to ensure that cells were subconfluent for
all experiments.
Total RNA was prepared using the Trizol reagent
(Invitrogen), and real-time RT-PCR was performed as
previously described (Erlebacher et al., 2002) using an
ABI Prism 7700 Sequence Detector (Applied Biosystems).
All reactions were run in duplicate using cDNA template
synthesized from 10 ng RNA, except for the amplification
of p15Ink4b, where 100 ng was used. CT values were
averaged, and DCT values were calculated relative to b-
actin. Transcript abundance relative to b-actin was calcu-
lated as 2DCT, and relative transcript abundance between
samples was calculated as 2(DCT, sample  DCT, reference).
Statistical significance was determined by Student’s t test
using groups of DCT values, and error bars were extrapo-
lated from the standard deviation of the DCT mean for each
group. In cases where an individual experiment is shown,
bars representing the error from duplicate sample runs are
omitted; CT duplicates were typically within 0.5 cycles,
corresponding to a standard deviation in expression level of
1.4-fold.
In addition to those described previously (Erlebacher et
al., 2002), we used the following primer or probe sets listed 5V
to 3V in the order of forward primer, reverse primer, and probe
(when employed): Tgfbr1 , gcgaacagaagttaaggccaaa,
gcaaagctgtcagccttgct, agctgtgaggccttgagagtgatggct; Tgfbr2,
tgcgcctggaccctactct, ccatgtatcttgccgttccc, acctggccaa-
cagcgggcag; Acvr1b , gggaccaaacgatacatggc, gggcata-
ga tg t cggcaca ; Acvr2a , a a c t t c c aaagggacgca t t t ,
catctacgggtccatctgca; Acvr2b , ccacgattaaggatcactggct,
atggtcccagcactcctcg; Smad2 , gcaggaattgagccacagagt,
cagccggagagcctgtgt; Smad3 , cctgggcctactgtccaatg,
ctctcccaatgtgtcgcctt; Smad4, cggtctttgtacagagttactacctgg,
actgccgcagatcaaagacct; Smad7, gggctttcagattcccaactt, cacag-
tagagcctccccacg; p15Ink4b , gaaattcttggatcatgtgtggg,
tttccttgtcgagctggagg, cacctgcaaaatggcatttatagaaactgagaagt;
p21Cip1 , cgagaacggtggaactttgac, tcccagacgaagttgccct,
tcgtcacggagacgccgctg; Id1 , cgacatgaacggctgctactc,
ttgctcactttgcggttctg, cgcctcaaggagctggtgccc; Id2, cctgcag-
cacgtcatcgat, cgatagtgggatgcgagtcc, acatcttggacctgca-
gatcgccc; c-myc, ctggatttcctttgggcgt, tggtgaagttcacgttgaggg,
aaaccccgcagacagccacgac; Mmp9, agcgtcattcgcgtggata, atgg-
cagaaataggctttgtcttg, ccctggaactcacacgacatcttccagt; PAI-1,
ctccacagcctttgtcatctcag, ccgaaccacaaagagaaaggatc; Plf ,
catctccaaagccacagacataaa, gttcttattttcttcatctcca; p57Kip2,
gccaatgcgaacgattctt, cgttcgacgccttgttctc, cgccaagcgcaaga-gaactgcg. All probes were dual-labeled with FAM and
TAMRA; SYBRGwas used for amplifications when a primer
set was used without a probe. For all reactions, the
approximate fold difference in amplification between plus
and minus RT reactions was N1000, except the SYBRG
amplifications of b-actin (50), p15Ink4b (25), p21Cip1
(50), PAI-1 (100), and Smad7 (500).
Analysis of DNA content
EGFP-TS3.5 cells were plated for 4 days in TS media
containing FGF4 and TGF-h or containing TGF-h-neutral-
izing antibodies. Cells were trypsinized, fixed in 40%
ethanol, treated with 50 mg/ml RNAase A (5 PrimeY3
Prime, Boulder, CO), and stained with 46 Ag/ml propidium
iodide (PI, Sigma) dissolved in 38 mM sodium citrate before
analysis by flow cytometry as above.
Blastocyst injections and immunostaining
Blastocysts derived from C57BL/6 matings were injected
with 15–20 trypsinized EGFP-TS3.5 cells previously grow-
ing N2 months in TS media supplemented with FGF4 and
TGF-h. Blastocysts were transferred into the uterine cavities
of pseudopregnant B6CBAF1 females using standard
techniques (Nagy et al., 2003). We implanted blastocysts
into four mice, which were sacrificed on E7–12. Embryonic
day was calculated relative to noon of the vaginal plug of
the pseudopregnant recipient (E0.5). Dissected placentas
and embryos were photographed using a Zeiss Stemi SV11
stereomicroscope equipped with GFP epifluorescence. All
mouse experiments were approved by the Standing Com-
mittee on Animals of Harvard Medical School.
Paraffin-embedded sections of placentas were stained
with a rabbit anti-GFP antibody (ab6556-25, Abcam,
Cambridge, MA; diluted 1/3000), followed sequentially by
a biotin-conjugated goat anti-rabbit secondary antibody
(Vector Laboratories, Burlingame, CA), horseradish perox-
idase-conjugated streptavidin, biotin–tyramide amplification
(NEN, Boston, MA), and lastly streptavidin-Alexa 594
(Molecular Probes, Eugene, OR). Sections were counter-
stained with DAPI (Sigma) and digitally photographed at
10 magnification.Results and discussion
TGF-b or activin is necessary and sufficient to maintain
trophoblast stem cell proliferation in the presence of FGF4
We identified TGF-h or activin as critical factors for
trophoblast stem cell maintenance using the TSInk4a
trophoblast stem cell line we had derived from Ink4a/
ArfD2,3 mice deficient in both the p16Ink4a and p19ARF
tumor suppressor genes (Erlebacher et al., 2002). This line
expressed a set of trophoblast markers (Eomes, Esrrb,
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cells, required both FGF4 and EFCM for continuous growth
and showed the same changes in gene expression upon
differentiation (Erlebacher et al., 2002). However, it is
important to note that the line had lost the tight epithelial
morphology typical of TS cells at around passage n = 12,
coinciding with an increase in growth rate (see below).
TSInk4a cells (n = 25–45) cultured in EFCM plus FGF4
ceased dividing within 4 days upon the addition of a
monoclonal antibody (1D11) that neutralizes all three TGF-
h isoforms (TGF-h1, -h2, and -h3), plus either an activin-
neutralizing chimeric protein (ActRIIB/Fc) consisting of the
extracellular domain of the ActRIIB receptor fused to a
human IgG1 Fc domain (Fig. 1D) or the natural activin
antagonist follistatin (Fig. 1F). The cells instead started to
assume a morphology typical of trophoblast giant cells in
culture (Tanaka et al., 1998), with an increase in nuclear and
total cell size, a flattening of the cells, and the appearance of
conspicuous perinuclear granules. In contrast, none of these
neutralizing reagents alone induced TSInk4a differentiation
after 4 days (Figs. 1B, C, and E), with the cells maintainingFig. 1. TGF-h and activin are the active components of EFCM that prevent TS cel
control mouse IgG antibodies (A, C, and E) or neutralizing anti-TGF-h antibodie
reagent (C and D) or activin-neutralizing follistatin (E and F). Cells were photogr
antibodies and either ActRIIB/Fc (D) or follistatin (F) inhibited proliferation an
morphology. Such cells showed a flattened appearance, increased nuclear and total
examples. Scale bar shows 200 Am.a similar morphology to that seen with culture in EFCM
plus FGF4 (Fig. 1A). Thus, we conclude that TGF-h or
activin are required to maintain TSInk4a cell proliferation,
and that both of these molecules are present in EFCM at
sufficient levels to independently prevent cell differentiation
in the short term.
Conversely, TGF-h or activin was sufficient to maintain
TSInk4a proliferation in the absence of EFCM, with culture
in FGF4 and either TGF-h or activin consistently improving
the growth rate after a few days over that seen with
continued culture in FGF4 and EFCM (Fig. 2A). In contrast,
TSInk4a culture in FGF4 alone with or without control
mouse IgG antibodies led to a cessation of cell proliferation
(Fig. 2A) and the induction of morphological differentiation
by day 4 as above. Importantly, differentiation induced upon
EFCM removal was accelerated by the addition of anti-
TGF-h neutralizing antibodies (Fig. 2A), implying that a
functionally relevant non-EFCM TGF-h source was also
present in our culture conditions. This source was likely a
combination of that produced by trophoblasts themselves
(Adelman et al., 2000), as well as that present in FCS, whichl differentiation. TSInk4a cells were plated in EFCM plus FGF4 containing
s (B, D, and F), with or without an activin-neutralizing ActRIIB/Fc fusion
aphed after 4 days. Only the combined addition of anti-TGF-h neutralizing
d induced differentiation in to cells with a typical trophoblast giant cell
cell size, and perinuclear granules. Arrows in panels D and F highlight two
Fig. 2. TGF-h or activin are sufficient to maintain TS cell proliferation in the presence of FGF4. (A) TSInk4a cells previously growing in EFCM plus FGF4
were plated in EFCM plus FGF4 or TS media plus FGF4 containing either TGF-h, activin, no additional supplementation, control mouse IgG antibodies, or
neutralizing anti-TGF-h antibodies. Cells were passaged and counted every 3 days. In the absence of EFCM, TGF-h, or activin, cells ceased proliferating and
underwent morphological differentiation. The difference in growth upon culture in control IgG antibodies versus anti-TGF-h antibodies reflects the
contribution of non-EFCM TGF-h either present in FCS or produced by trophoblasts themselves. (B) EGFP-TS3.5 cells previously growing in EFCM plus
FGF4 were plated and passaged as in panel A. For both growth curves, data points shown mean F SD of triplicate wells and data are representative of three
independent experiments. (C–H) Morphology of EGFP-TS3.5 in various growth conditions. Cells previously growing in EFCM plus FGF4 were photographed
after 9 days of culture in EFCM plus FGF4 (C) or TS media plus FGF4 and either TGF-h (D), activin (E), no additional supplementation (F), control mouse
IgG antibodies (G), or neutralizing anti-TGF-h antibodies (H). EGFP-TS3.5 maintained its tight epithelial morphology only in the presence of EFCM, TGF-h,
or activin. In the absence of further supplementation (F) or in the presence of control mouse IgG antibodies (G), the cells assumed a giant cell morphology by
day 9. This process was accelerated in presence of anti-TGF-h antibodies, where by day 9 the culture was largely degenerated (H). Scale bar shows 200 Am.
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range of 1–5 ng/ml mature active TGF-h plus unprocessed
latent TGF-h (O’Connor and Wakefield, 1987; Wight,
2000). Latent TGF-h was possibly made available to
trophoblasts after proteolytic processing by matrix metal-
loproteinase-9 (MMP-9), a known activator of TGF-h
expressed by trophoblast giant cells in vivo (Alexander et
al., 1996; Yu and Stamenkovic, 2000) but also at high levels
by TS cells in vitro (see below).
TGF-h or activin was also able to maintain wild-type TS
cell proliferation in the absence of EFCM. Thus, the
enhanced green fluorescent protein-expressing TS cell line
EGFP-TS3.5 (Tanaka et al., 1998) cultured with FGF4 and
either TGF-h (Fig. 2D) or activin (Fig. 2E) showed the same
tight epithelial morphology and growth rate (Fig. 2B) seen
with continued culture in FGF4 and EFCM (Figs. 2B and
C). In contrast, culture in FGF4 alone with or without
control mouse IgG antibodies led to a high degree of
morphological differentiation by day 9 (Figs. 2F and G), and
although the cells had largely maintained their proliferation
rate up until this point (Fig. 2B), they were unable to sustainlonger term culture in the absence of exogenous TGF-h or
activin. As above, the temporary maintenance of EGFP-
TS3.5 proliferation was due to a non-EFCM TGF-h source,
as the addition of neutralizing anti-TGF-h antibodies led to
a rapid decrease in cell proliferation and assumption of a
giant cell morphology by day 6 (Figs. 2B and H).
Since TGF-h-neutralizing antibodies accelerated the
differentiation of both TSInk4a and EGFP-TS3.5, an auto-
crine or FCS-derived TGF-h source was functionally
relevant toward the differentiation of both cell lines in the
absence of EFCM. Thus, the faster rate of TSInk4a versus
EGFP-TS3.5 differentiation upon EFCM withdrawal (Figs.
2A versus B) might reflect a relatively higher level of
autocrine TGF-h secretion by EGFP-TS3.5 or a higher
capacity to activate latent FCS-derived or autocrine TGF-h.
It might also reflect the higher sensitivity of TSInk4a to
abrupt shifts in extracellular TGF-h concentrations also
evident with its more dramatic TGF-h transcriptional
response (see below) or simply a requirement by TSInk4a
for higher concentrations of TGF-h. While the difference in
TSInk4a and EGFP-TS3.5 differentiation kinetics might also
A. Erlebacher et al. / Developmental Biology 275 (2004) 158–169 163directly or indirectly result from the Ink4a/Arf mutation in
TSInk4a, the overall dependence of both lines on TGF-h/
activin is clearly conserved.
Maintenance of stem cell characteristics of TS cells grown
in FGF4 and TGF-b
Several criteria support the conclusion that long-term
culture in FGF4 and TGF-h is sufficient to maintain the
stem cell characteristics of TS cells. First, the expression of
a number of trophoblast stem cell markers was maintained
after culture N1.5 months in media supplemented with only
FGF4 and TGF-h, as compared to their expression during
culture in FGF4 and EFCM (Fig. 3A). Specifically, we
found similar levels of expression of Eomes, which encodes
a T-box family transcription factor required in vivo for TS
cell lineage determination (Russ et al., 2000); Esrrb, which
encodes Errh, an orphan nuclear receptor required for
continued TS cell proliferation (Luo et al., 1997); Fgfr2,
which encodes the likely relevant FGF receptor expressed
by trophoblasts (Rossant and Cross, 2001); and Cdx2,
which encodes a caudal-type transcription factor likely alsoFig. 3. Maintenance of TS cell stem cell characteristics upon long-term culture in
FGF4 plus TGF-h for N1.5 months. (A) Expression of trophoblast stem cell mar
occasions and compared to two RNA isolates from EGFP-TS3.5 cells growing in F
Only the twofold higher expression of Mash2 in cells grown in FGF4 plus T
trophoblast differentiation markers upon removal of FGF4 and TGF-h. Cells w
containing TGF-h-neutralizing antibodies. Fold changes in expression were deter
independent experiments. (C) Increase in DNA content upon removal of FGF4 and
plus TGF-h showed two prominent peaks, corresponding to 2 N DNA content (d
lower number of cells showed N4 N DNA content, consistent with the low level o
plus EFCM (Tanaka et al., 1998). After a 4-day growth factor withdrawal as in pan
Data shown are representative of two independent experiments.required for TS cell lineage determination in vivo (Cha-
wengsaksophak et al., 1997). Furthermore, there was no
change in the expression of Hand1, which encodes a bHLH
transcription factor required for giant cell differentiation but
also expressed by TS cells (Cross et al., 2003; Tanaka et al.,
1998). The only statistically significant change in expres-
sion was a twofold up-regulation of Mash2, which encodes
a bHLH transcription factor required for the development of
spongiotrophoblasts and their progenitors (Guillemot et al.,
1994).
Second, we found that the capacity for biochemical
differentiation of TS cells was preserved after culture for
N1.5 months in FGF4 and TGF-h. As described previously
for TS cells growing in FGF4 plus EFCM (Tanaka et al.,
1998), removal of both factors led to increased expression
of the giant cell marker placental lactogen-1 (Pl-1) and the
ectoplacental cone and spongiotrophoblast marker Tpbp
(Fig. 3B). In addition, we found that removal of FGF4 and
EFCM up-regulated expression of another giant cell marker
Proliferin (Plf), as well as the cdk inhibitor p57Kip2, in
line with the role of this cell cycle inhibitor in TS cell
differentiation to both trophoblast giant cell and spongio-FGF4 and TGF-h. EGFP-TS3.5 cells were grown in TS media containing
kers. Real-time RT-PCR was performed on RNA isolated on two different
GF4 plus EFCM. Data show mean F SD for these two RNA preparations.
GF-h was statistically significant ( Pb0.05). (B) Increased expression of
ere cultured for 4 days in media lacking either growth factor and instead
mined relative to the zero time point and represent the mean F SD of two
TGF-h, as determined by propidium iodide staining. Cells growing in FGF4
iploid cells in G1) or 4 N (diploid cells in G2 or tetraploid cells in G1). A
f spontaneous trophoblast differentiation also seen during culture in FGF4
el B, there was an increase in the number of cells with N4 N DNA content.
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et al., 1998). Third, removal of FGF4 and TGF-h increased
the number of cells with DNA content greater than 4 N
(Fig. 3C), as expected during the generation of polyploid
trophoblast giant cells (Tanaka et al., 1998). In these last
two experiments, we accentuated the effects of exogenous
TGF-h withdrawal by additionally adding TGF-h-neutral-
izing antibodies.Fig. 4. Generation of chimeric placentas following blastocyst injection of EGFP-
FGF4 and TGF-h. (A and B) Whole-mount photographs of the undersides of a non
an extensive contribution of EGFP+ cells. Corresponding embryos (C and D) show
analysis of the placentas shown in panels A and B, respectively. EGFP-TS3.5-deriv
and all nuclei were stained blue with DAPI. In the chimeric placenta (F), EGFP+ ce
in the spongiotrophoblast layer (S). The giant cell layer is above the photographic f
secondary trophoblast giant cell layer (arrowheads) at the interface between the
examined, two showed a high degree of chimerism and three showed a low degree
sac, allantois, or amnion. Magnification in A–D is 0.8; scale bar in E shows 50Lastly, EGFP-TS3.5 cells maintained 2 months in FGF4
plus TGF-h could contribute towards chimeric placentas
following their injection into blastocysts, as described
previously for TS cells grown in FGF4 plus EFCM (Tanaka
et al., 1998). Thus, Fig. 4B shows an E12.5 placenta with a
large contribution of EGFP+ cells, whereas its corresponding
embryo (Fig. 4D) and other nonplacental structures (yolk sac,
allantois, and amnion; not shown) showed no EGFP-TS3.5TS3.5. Cells had been growing N2 months in TS media supplemented with
chimeric (A) and chimeric (B) E12.5 placenta. The chimeric placenta shows
no EGFP+ cells and only background fluorescence. (E and F) Histological
ed cells were identified by immunostaining with an anti-GFP antibody (red),
lls are contributing extensively to the labyrinth (L), with a few scattered cells
ield. (G) An E10.5 chimeric placenta showing an EGFP+ contribution to the
placenta (Pl) and the maternal decidua (Dec). Of the 28 E7–12 concepti
of chimerism. No conceptus showed EGFP+ cells in the embryo proper, yolk
0 Am.
A. Erlebacher et al. / Developmental Biology 275 (2004) 158–169 165contribution. At the histological level (Fig. 4F), visualization
of injected cells in this placenta with an anti-GFP antibody
showed extensive contribution to the placental labyrinth (L)
and sparse contribution to the spongiotrophoblast layer (S).
For comparison, a nonchimeric placenta and embryo are
shown in Figs. 4A, C, and E. Fig. 4G shows an E10.5 placenta
where EGFP+ cells (arrowheads) have contributed to the
secondary trophoblast giant cell layer that forms the external
shell of the placenta (Pl), directly abutting the maternal
decidua (Dec). The variable contribution of these injected TS
cells towards different trophoblast subtypes in different
placentas is consistent with the prior description of TS cell
behavior (Tanaka et al., 1998).
Differential regulation of trophoblast stem cell marker
expression by FGF4 and TGF-b
To gain insight into how FGF4 and TGF-h might
differentially regulate TS cell behavior, we determined the
3-day temporal expression patterns of several genes
involved in trophoblast stem cell maintenance upon
selective growth factor withdrawal from EGFP-TS3.5,
using cells that had been previously growing N1.5 months
in media supplemented with only FGF4 and TGF-h. Since
the presence of an autocrine or FCS-derived TGF-h source
would moderate the effects of exogenous TGF-h with-
drawal, we accentuated the withdrawal response by
simultaneously adding anti-TGF-h neutralizing antibodies
as above. As shown in Fig. 5, FGF4 withdrawal led to
rapid down-regulation of both Eomes and Esrrb, suggest-
ing that these two genes might be primary FGF4 targets
critical for TS cell maintenance in vitro. Although down-
regulation of both genes also occurred upon selectiveFig. 5. Changes in TS cell gene expression upon selective growth factor withdraw
FGF4 and TGF-h were plated at the 0-h time point in this same media, in TS m
supplemented only with FGF4 and containing TGF-h-neutralizing antibodies (TG
(Esrrb), 0.79 (Id2), 6.58 (Fgfr2), 9.63 (Cdx2), and 1.39 (Mmp9).TGF-h withdrawal, the effect was delayed and less
dramatic than that seen with FGF4 withdrawal. These
more mild decreases in expression might reflect a require-
ment for TGF-h to secondarily maintain optimal FGF
signaling since TGF-h withdrawal also led to decreased
expression of Fgfr2 (Fig. 5).
In contrast to Eomes and Esrrb, selective FGF4 or TGF-
h withdrawal led to a similar and rapid down-regulation of
Cdx2 as well as Mmp9 (Fig. 5). Thus, these genes might
represent common targets for FGF4 and TGF-h, and their
maintained expression by TGF-h might be important
mechanisms for TS cell maintenance. Interestingly, FGF4
withdrawal led to strongly decreased Id2 mRNA expression
only after 48 h, which is after the initial down-regulation of
Eomes and Esrrb, while TGF-h withdrawal led to Id2
down-regulation even later (Fig. 5). Thus, down-regulation
of Id2 , which is expressed at very high levels in
undifferentiated TS cells (near the level of b-actin and
1000-fold greater than the expression level of Id1), is
unlikely a primary event in trophoblast differentiation.
Conversely, Id1 (data not shown) and Id2 (see below) were
not rapidly induced by de novo addition of TGF-h to TS
cells. This stands in contrast to the rapid induction of Id
gene expression by BMP4 in embryonic stem (ES) cells and
the key requirement for this induction to maintain ES cells
in an undifferentiated state (Ying et al., 2003).
Inhibition of cytostatic TGF-b signaling by FGF4
Since TS cells are epithelial and nontransformed, it was
surprising that they were not growth inhibited by TGF-h. To
explore the basis of this phenotype, we characterized the
transcriptional responses of TS cells towards TGF-h, takingal. EGFP-TS3.5 cells growing previously in TS media supplemented with
edia supplemented only with TGF-h (FGF4 withdrawal), or in TS media
F-h withdrawal). The 0-h DCTs relative to b-actin were 5.11 (Eomes), 4.63
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selected on the basis of continued growth in the absence of
EFCM (Erlebacher et al., 2002). This line maintained high
expression of all trophoblast stem cell markers tested and
retained the capacity to undergo morphological and bio-
chemical differentiation upon FGF4 withdrawal (Erlebacher
et al., 2002). The use of TSCMI, however, allowed us to
determine de novo TGF-h transcriptional responses since
TSCMI growth did not require the continuous addition of
exogenous TGF-h. Nonetheless, these cells still required
some level of extracellular TGF-h stimulation since they
differentiated upon addition of anti-TGF-h antibodies (data
not shown). Presumably, TSCMI had undergone genetic or
epigenetic alterations that either up-regulated autocrine
TGF-h expression or led to increased activation of FCS-
derived TGF-h, amplified the TGF-h signaling induced by
these potential TGF-h sources, or accommodated reduced
TGF-h signaling more distally.
Addition of TGF-h to TSCMI previously growing N1.5
months in media supplemented only with FGF4 rapidly
down-regulated mRNA expression of Id2 and induced
expression of Mmp9 as well as the well-characterized
TGF-h target genes plasminogen activator inhibitor-1
(PAI-1) and Smad7 (Massague and Wotton, 2000) (Fig.
6A). In contrast, TGF-h had no significant sustained effect
on the mRNA levels of p15Ink4b, p21Cip1, and most
importantly c-myc. Thus, while the overall transcriptional
response towards TGF-h was clearly intact, critical compo-
nents of the cytostatic response were absent, a situation
reminiscent of the selective alterations in TGF-h signaling
seen in some cell lines following transformation with
oncogenic Ras (Chen et al., 2001). Since FGF receptors
are receptor tyrosine kinases and thus activate the Ras/Mek/
Erk mitogen-activated kinase (MAPK) pathway, it was
possible that constitutive engagement of the FGF receptor
by FGF4 was having a similar effect on TGF-h signaling in
TS cells.
To test this idea, we determined the de novo transcrip-
tional response of TSCMI towards TGF-h in the presence or
absence of FGF4. We accentuated TGF-h-dependent effects
by comparing media supplemented with TGF-h to media
without TGF-h supplement and instead containing anti-
TGF-h neutralizing antibodies to reduce the effects of
autocrine or FCS-derived TGF-h. As shown in Fig. 6B,
addition of TGF-h to TSCMI while simultaneous removing
the FGF4 led to a rapid and sustained four- to fivefold
down-regulation of c-myc expression that persisted for up to
48 h. The c-myc down-regulation was TGF-h dependent
and not simply due to FGF4 withdrawal since it was not
seen in media containing neutralizing anti-TGF-h anti-
bodies. In contrast, and in agreement with the above results,
TGF-h added in the continued presence of FGF4 had no
sustained effect on c-myc mRNA levels. The inhibitory
effect of FGF4 on TGF-h signaling appeared gene specific
since the induction of PAI-1 or Smad7 by TGF-h was not
inhibited in the presence of FGF4 (Fig. 6B).Since they need exogenous TGF-h (or EFCM) for
continuous growth, we could not perform a directly parallel
experiment with wild-type TS cells. Thus, we first tried
culturing EGFP-TS3.5 in the absence of TGF-h for 24 h
before the 0-h time point so that we could detect TGF-h
responses upon restimulation as above. Under these
conditions, TGF-h addition concurrent with FGF4 removal
led to a sustained twofold c-myc mRNA down-regulation
not seen in the presence of FGF4 (data not shown). This
more attenuated response compared to TSCMI was also
apparent in the less robust transcriptional induction of PAI-1
and Smad7 (data not shown) and may reflect a differential
sensitivity towards TGF-h in the two cell lines. Since 24 h
culture in the absence of TGF-h before restimulation may
have altered subsequent gene regulation, however, we also
sought independent evidence of the c-myc transcriptional
effect during primary growth factor withdrawal. Thus, we
cultured EGFP-TS3.5 previously growing in FGF4 plus
TGF-h in media containing both factors, media selectively
removing FGF4, media selectively removing TGF-h, or
media removing both growth factors. For conditions
removing TGF-h, we additionally added TGF-h-neutraliz-
ing antibodies to attenuate the effect of FCS-derived or
autocrine TGF-h. As shown in Fig. 6C, selective removal of
FGF4 caused a reproducible threefold decrease in c-myc
transcript levels after 24 h, whereas selective removal of
TGF-h or removal of both growth factors had no effect on c-
myc mRNA expression levels. Thus, c-myc down-regulation
required both the presence of TGF-h and the absence of
FGF4. This strongly suggests that constitutive FGF4
signaling in wild-type TS cells prevents the cytostatic
TGF-h transcriptional response and may explain why
TGF-h acts as growth promoter rather than a growth
inhibitor in TS cells.
Maintenance of TS cell proliferation by FGF4 and
TGF-b/activin: in vivo correlations
During mouse development, trophoblast stem cells
formed in the polar trophectoderm by E4.5 are thought to
proliferate within the extraembryonic ectoderm up until
about E7.5 (Cross et al., 2003; Rossant and Cross, 2001).
This process is thought to require the actions of FGF4
secreted by the underlying inner cell mass and its derivative
the epiblast. Our demonstration that TGF-h or activin is also
required for TS cell proliferation in vitro raises the question
of what TGF-h superfamily ligand and receptor pairs are
relevant for TS cell growth in vivo. Despite expression of
the three TGF-h isoforms in varying patterns within the
maternal decidua or ectoplacental cone (Adelman et al.,
2000; Manova et al., 1992), TGF-h is not absolutely
required for TS cell development since embryos deficient
in either Tgfbr1 or Tgfbr2, which encode the two TGF-h
receptors, die at mid-gestation (Chang et al., 2002). In
contrast, embryos deficient in Acvr1b, which encodes
ActRIB, die by E8.5 with defects including a disorganized
Fig. 6. Regulation of TGF-h transcriptional responses in TS cells by FGF4. (A) Time course of the transcriptional responses of TSCMI towards TGF-h. mRNA
levels relative to b-actin (DCT values) were determined by real-time RT-PCR, then normalized to each 0-h time point, respectively. The 0-h DCTs were 2.58
(Id2), 4.20 (Mmp9), 6.74 (PAI-1), 5.53 (Smad7), 6.31 (c-myc), 19.11 (p15Ink4b), and 11.53 (p21Cip1). Data are representative of two independent
experiments. (B) Influence of FGF4 on the transcriptional responses of TSCMI towards TGF-h. Cells previously growing in FGF4 were stimulated with TGF-
h or TGF-h-neutralizing antibodies in the presence or absence of FGF4. RNAwas isolated at 0, 4, 24, and 48 h. The 0-h DCTs relative to b-actin were 6.07 (c-
myc), 6.32 (PAI-1), and 6.71 (Smad7). Data are representative of two independent experiments. (C) Regulation of c-myc expression in EGFP-TS3.5. Cells
previously growing in FGF4 and TGF-h were plated in TS media containing both factors, media selectively removing FGF4, media selectively removing TGF-
h, or media removing both growth factors. TGF-h neutralizing antibodies were added in conditions removing TGF-h. RNAwas prepared after 24 h, and c-myc
mRNA expression levels were determined by real-time RT-PCR. Fold changes in expression were calculated relative to the c-myc expression level in cells
plated in FGF4 and TGF-h. Removal of FGF4 in the continued presence of TGF-h led to a threefold decrease in c-myc abundance (*P b 0.05). Data represent
the meanF SEM of all data from three independent experiments with all four treatment groups, plus an additional experiment that did not involve plating cells
in the absence of both growth factors.
A. Erlebacher et al. / Developmental Biology 275 (2004) 158–169 167extraembryonic ectoderm apparent by E6.5 (Gu et al.,
1998), and embryos doubly deficient in Acvr2 and Acvr2b,
which encode the two type II activin receptors, die by E8.5
with a severe growth retardation of both embryonic and
extraembryonic tissue apparent by E7.5 (Song et al., 1999).
It is possible that these phenotypes might in part involve
loss of the direct actions of activin on the extraembryonic
ectoderm since this structure expresses all three activin
receptors (Gu et al., 1998; Manova et al., 1995). If activin isa relevant ligand, however, its source is unlikely to be
exclusively embryonic since ablation of the two activin gene
isoforms (hA and hB, which as homo- and heterodimers,
encode mature activin) causes death in the perinatal period
(Matzuk et al., 1995). The death of these embryos, however,
precludes testing the relevance of a maternal activin source,
although the expression of activin hA and hB in the decidual
tissue surrounding the embryo starting by E5.0–5.5 is
suggestive (Albano et al., 1994; Manova et al., 1992).
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excellent candidate for a factor maintaining TS cell
proliferation in vivo, perhaps one that acts a bit later than
activin. Nodal is expressed in the epiblast and in con-
junction with the epidermal growth factor-related molecule
Cripto signals via activin receptors and Smad2 and Smad3
(Schier, 2003). Defects observed in Nodal/ embryos by
E9.5 include a loss of the spongiotrophoblast and placental
labyrinth and an overgrowth of trophoblast giant cells,
consistent with a failure of pluripotential TS cell main-
tenance (Iannaccone et al., 1992; Ma et al., 2001).
Furthermore, transfection of TS cells with a nodal expres-
sion construct partially inhibits differentiation upon FGF4
and EFCM removal (Ma et al., 2001).
Although we have described some trophoblast-specific
transcriptional responses to TGF-h and FGF4, how these
factors prevent TS cell differentiation is unclear and may
involve complex interactions between Smad-signaling path-
ways activated by TGF-h/activin/Nodal and Ras/Mek/Erk
pathways activated by FGF4. Furthermore, TGF-h/activin/
Nodal might inhibit TS cell differentiation through non-
Smad-signaling pathways (Derynck and Zhang, 2003) or
through Smad-dependent mechanisms aside from the direct
transcriptional regulation of Smad target genes. For exam-
ple, activated Smad proteins inhibit myoblast, osteoblast,
and adipocyte differentiation by interfering via direct
physical interaction with the function of more cell-type-
specific transcription factors (Alliston et al., 2001; Choy and
Derynck, 2003; Liu et al., 2001).
Our data suggest that in contrast to the possible
requirement of TGF-h for optimal FGF signaling (see
above), FGF4 was not conversely required for global
TGF-h signaling. Thus, FGF4 withdrawal from EGFP-
TS3.5 had no acute effects on the mRNA levels of Tgfbr1,
Tgfbr2, Acvr1b, Acvr2, Acvr2b, Smad2, Smad3, or
Smad4, with two- to fivefold decreases in mRNA levels
for some of these genes seen on day 3 (data not shown).
Furthermore, only withdrawal of TGF-h, but not FGF4,
led to the acute down-regulation of the Smad target genes
PAI-1 and Smad7 (data not shown). However, FGF4 may
have an influence on TGF-h availability in vivo by
regulating expression of MMP-9, a proteolytic activator of
latent TGF-h, and may modify the regulation of Smad
target genes on a selective basis. One important example
of this comes from our data suggesting that FGF
signaling constitutively attenuates the cytostatic TGF-h
transcriptional response in a manner similar to that
previously seen in some Ras-transformed tumor cells of
epithelial origin (Chen et al., 2001). Additional experi-
ments are needed to determine how this pathway relates
to the other more general Ras/Mek/Erk-dependent mech-
anisms described for preventing TGF-h-induced growth
arrest or modifying TGF-h transcriptional responses
(Derynck and Zhang, 2003). However, it is likely that
the pathway is active in vivo since FGF-dependent Erk
activity is constitutive in the extraembryonic ectodermcontaining TS cells (Corson et al., 2003). It is conceiv-
able that similar pathways may also play a role elsewhere
during development or as a component of epithelial stem
cell maintenance in adults. For example, high circulating
levels of activin have been shown to expand gastric
epithelial progenitors in vivo (Li et al., 1998). Lastly,
these intersecting pathways might provide a physiological
mechanism for rapid and synchronous TS cell differ-
entiation upon exposure to decreased FGF4 concentrations
in the presence of constant TGF-h/activin/Nodal levels, as
the requirement for TGF-h signaling to maintain stem cell
proliferation would now switch to a stimulus for cell
cycle arrest.Note added in proof
We have been able to derive two new independent TS
cell lines following the individual culture of twelve
blastocysts in DMEM/F12-based TS media supplemented
with only FGF4, activin, and anti-TGF-h antibodies. At
passage n = 7–8, these lines showed the epithelial
morphology and trophoblast stem cell marker expression
profile typical of other established TS cell lines, and
showed a similar pattern of stem cell marker gene
downregulation and morphological differentiation upon
removal of either FGF4 or activin. These results suggest
that activin is sufficient to establish TS cell lines de novo
in the absence of EFCM.Acknowledgments
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